Immune Checkpoint Inhibitor Related Myositis/Myasthenia Gravis Overlap Syndrome Treated with Eculizumab

被引:0
|
作者
Hewitt, Sage
Wang, Danfeng
Poursheykhi, Meryim
Patel, Shaily
Shah, Shailee
机构
关键词
D O I
10.1212/01.wnl.0001051900.06940.ea
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S131 / S132
页数:2
相关论文
共 50 条
  • [21] Life-threatening immune checkpoint inhibitor-induced myocarditis and myasthenia gravis overlap syndrome treated with abatacept: a case report
    Wakefield, Chelby
    Shultz, Carl
    Patel, Brijesh
    Malla, Midhun
    BMJ CASE REPORTS, 2021, 14 (11)
  • [22] Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
    Verma, Neha
    Jaffer, Muhammad
    Pina, Yolanda
    Peguero, Edwin
    Mokhtari, Sepideh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [23] Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review
    Gao, Loulu
    Li, Xuemei
    Guo, Zhijun
    Tang, Lin
    Peng, Jieqiong
    Liu, Bo
    MEDICINE, 2022, 101 (49) : E32240
  • [24] IMMUNE CHECKPOINT INHIBITOR-RELATED MYASTHENIA GRAVIS: A CASE REPORT
    Agrawal, Simran
    Yeboah-Kordieh, Yvette
    Hedayati, Gilava
    Jaller, Alejandro
    Singh, Jasvinder
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [25] Case of Immune Checkpoint Inhibitor Induced Myasthenia Gravis
    Gullapalli, Manoja
    Arulprakash, Narenraj
    Safar, Mazin
    Kocurek, Emily
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [26] IMMUNE CHECKPOINT INHIBITOR-MEDIATED MYASTHENIA GRAVIS
    Ho, Adrienne K.
    Cooksley, Tim
    JOURNAL OF EMERGENCY MEDICINE, 2020, 59 (04): : 561 - 562
  • [27] Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
    Huang, Yi-Te
    Chen, Ya-Ping
    Lin, Wen-Chih
    Su, Wu-Chou
    Sun, Yuan-Ting
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [28] CONCURRENT MYASTHENIA GRAVIS, MYOCARDITIS, AND MYOSITIS SECONDARY TO IMMUNE CHECKPOINT INHIBITORS
    Rode, Shomita
    Reed, Mark
    Parker, William A.
    Johnson, Jeremy C.
    Kalanjeri, Satish
    CHEST, 2024, 166 (04) : 2693A - 2694A
  • [29] OVERLAP OF MYASTHENIA GRAVIS AND MYOSITIS IS A COMMON ETIOLOGY OF NEUROMUSCULAR WEAKNESS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY IN A MULTICENTER RETROSPECTIVE STUDY OF 15 PATIENTS
    Guidon, Amanda
    Raja, Shruti
    Dubey, Divyanshu
    Clement, Nathan
    Reynolds, Kerry
    Guptill, Jeffrey
    David, William
    MUSCLE & NERVE, 2018, 58 : S99 - S99